GABELLI FUNDS LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 33 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$2,943,000
+1.7%
2,500,0000.0%0.02%
+5.9%
Q4 2017$2,894,000
-2.6%
2,500,0000.0%0.02%0.0%
Q3 2017$2,970,000
-11.2%
2,500,0000.0%0.02%
-15.0%
Q2 2017$3,345,000
+7.6%
2,500,0000.0%0.02%
+11.1%
Q1 2017$3,108,000
+8.6%
2,500,0000.0%0.02%
+5.9%
Q4 2016$2,861,000
+20.0%
2,500,000
+25.0%
0.02%
+21.4%
Q3 2016$2,384,0002,000,0000.01%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Mohican Financial Management, LLC 2,000,000$2,676,0004.66%
LINDEN ADVISORS LP 61,156,000$82,021,0003.46%
SSI INVESTMENT MANAGEMENT LLC 9,719,000$13,007,0001.15%
CSS LLC/IL 15,280,000$20,475,0000.99%
TENOR CAPITAL MANAGEMENT Co., L.P. 7,500,000$10,070,0000.92%
Castle Creek Arbitrage, LLC 4,000,000$5,361,0000.58%
DAFNA Capital Management LLC 573,000$767,0000.55%
WOLVERINE ASSET MANAGEMENT LLC 30,968,000$41,494,0000.53%
Polar Asset Management Partners Inc. 15,000,000$20,086,0000.47%
OAKTREE CAPITAL MANAGEMENT LP 19,584,000$26,612,0000.44%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders